Drug · DIN 02469057
PHARMA-RAMIPRIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 16, 2018; first marketed April 16, 2018.
- Drug Identification Number (DIN)
- 02469057
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Ramipril C09AA05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RAMIPRIL | 1.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 17, 2017: NOC 19922Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named PHARMA-RAMIPRIL
- DIN 02469065 · Marketed
- DIN 02469073 · Marketed
- DIN 02469081 · Marketed